Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule

Inclusion Criteria: * A healthy male or female adult aged between 18 and 40 years. * Written informed consent obtained from the subject Exclusion Criteria: * Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine(s) within 30 days preceding the first dose of study vaccine, or planned use during the study period. * Chronic administration of immunosuppressants or other immune-modifying drugs within six months prior to the first vaccine dose. * Administration of a vaccine not foreseen by the study protocol within 14 days (killed vaccine) or 30 days (attenuated/ live vaccine) before the first vaccine dose. * Concurrently participating in another clinical study or exposure to an investigational or a non-investigational product (pharmaceutical product or device). * History of hepatitis B infection. * Known exposure to hepatitis B virus within 6 months. * Any confirmed or suspected immunosuppressive or immunodeficient condition, based on medical history and physical examination. * Pregnant or lactating female. * Female planning to become pregnant or planning to discontinue contraceptive precautions.